Investigator
Yu-Chih Chen
UNIVERSITY OF PITTSBURGH AT PITTSBURGH · funded by NCI, NIGMS
- Companies
- 2
- Grants
- 3
- Non-dilutive funding
- $781k
- First award
- Aug 1, 2023
Resolved onto their grants.
Federal awards on file.
Summed across those awards.
Latest May 1, 2025.
Companies from this work
Pre-ticker companies the crosswalk resolved onto a grant filed under this investigator. Momentum shows for the therapeutic areas your seat covers; open a dossier for the full crosswalk.
- Guangdong Association of Clinical Trials100momentum
OncologyPhase III
- Nanjing Leads Biolabs Co.,Ltd100momentum
OncologyFiled/Approved
Grant record
Federal awards filed under this investigator name, newest first. Each links to the public record where the awarding agency publishes one.
- R21
Halting Breast Cancer Metastasis by Blocking Cancer-MSC Engulfment
$181kMay 1, 2025NCIUNIVERSITY OF PITTSBURGH AT PITTSBURGHNIH RePORTER · 11125028 (opens the source filing in a new tab)
- R21
Halting Breast Cancer Metastasis by Blocking Cancer-MSC Engulfment
$218kMay 1, 2025NCIUNIVERSITY OF PITTSBURGH AT PITTSBURGHNIH RePORTER · 11321699 (opens the source filing in a new tab)
- R35
Deciphering Cellular Heterogeneity and Inheritability in Migration
$383kAug 1, 2023NIGMSUNIVERSITY OF PITTSBURGH AT PITTSBURGHNIH RePORTER · 11134731 (opens the source filing in a new tab)
This page aggregates public U.S. federal grant records filed under one investigator name and the companies Biodatica has resolved onto them. Names are shown as the awarding agency filed them; grant awards are non-dilutive federal funding, not equity or valuation. Distinct people who file under the same name would appear together here. It is informational only and not investment advice. Methodology · Data sources